Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy

NCT00832572 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of enrollment

Conditions

Coronary Artery Disease
Pain
Peripheral Nervous System Diseases
Polyneuropathy

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Gilead Sciences